Role of Single Procalcitonin Test on Admission as a Biomarker for Predicting the Severity of Clostridium difficile Infection
Objective: To evaluate whether serum Procalcitonin (PCT) at the early stage of infection can serve as a potential biomarker for determining Clostridium difficile infection (CDI) severity.Methods: Fifty-four patients diagnosed with CDI were enrolled in the study. Serum samples were obtained within a...
Main Authors: | Zohar Hamo, Maya Azrad, Orna Nitzan, Asaf Sagie, Linda Tkhawkho, Dana Binyamin, Avi Peretz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmicb.2017.02532/full |
Similar Items
-
In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
by: Dana Binyamin, et al.
Published: (2018-06-01) -
The microbial diversity following antibiotic treatment of Clostridioides difficile infection
by: Dana Binyamin, et al.
Published: (2021-04-01) -
Characterization of the Immune Response during Infection Caused by <i>Clostridioides difficile</i>
by: Zohar Hamo, et al.
Published: (2019-10-01) -
Molecular Characterization and Moxifloxacin Susceptibility of <i>Clostridium difficile</i>
by: Sarah Mizrahi, et al.
Published: (2019-08-01) -
IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of <i>C. difficile</i> Infection
by: Dor Gotshal, et al.
Published: (2021-05-01)